Atlas Capital Advisors LLC Astrazeneca PLC Transaction History
Atlas Capital Advisors LLC
- $788 Billion
- Q4 2024
A detailed history of Atlas Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Atlas Capital Advisors LLC holds 4,098 shares of AZN stock, worth $304,235. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,098
Previous 5,509
25.61%
Holding current value
$304,235
Previous $429 Million
37.44%
% of portfolio
0.03%
Previous 0.07%
Shares
22 transactions
Others Institutions Holding AZN
# of Institutions
1,366Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.48 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.05 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.78 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.75 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.78 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $230B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...